Asthma
COPD
Pulmonary
Pulmonary: Page 19
Could hair predict pulmonary fibrosis?
An exploratory study evaluated the use of hair metabolites to diagnose and measure the disease.
July 25, 2024
The proof (for PH) may be in plants
Researchers identify plant substance that may reverse pulmonary hypertension.
July 22, 2024
Respiratory bacteria disable immune system
Study findings show how a common bacterium survives through illness.
July 19, 2024
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Potential cell therapy option for NSCLC
Clinical trial evaluates use of TIL therapy to destroy lung cancer tumor cells.
July 8, 2024
Positive results for investigational drug brensocatib
Insmed presented additional data from its ASPEN study at the World Bronchiectasis Conference.
July 8, 2024
A microrobotic feat of engineering
Green algae-based microrobots improve lung cancer survival time by almost 40% in mouse models.
July 3, 2024
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
Using acetaminophen to help treat sepsis patients
NIH researchers evaluate the therapy for critically ill patients at risk of organ damage and respiratory distress.
July 3, 2024
ALA announces online Wellness Hub for lung disease community
The new hub, part of ALA’s Patient & Caregiver Network, will provide physical and mental health benefits for people living with lung disease.
June 26, 2024
Impact of FOXF1 on rare pediatric lung disease
Study on gene protein may also have implications for common pulmonary conditions.
June 25, 2024
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
Leveraging AI to predict, diagnose lung cancer
A novel lab-based blood test could move the needle on leading cause of cancer in the U.S.
June 20, 2024
PAH drug trial falls short
Aerovate ends study early upon failing to meet clinical endpoints for its sole product.
June 18, 2024
RNA-based CF therapy gets the fast track
Biotech company SpliSense moves forward in development of ASO product to treat cystic fibrosis.
June 13, 2024
Previous Page
Page 19 of 29
Next Page
Most Popular
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
FDA approves study of inhaled stem cell therapy for COPD
Common cold: There may be a vaccine for that
Semaglutide significantly lowers asthma, COPD attacks
Novel inhaled treatment for COPD shows promise in clinical trial
Childhood pollution exposure linked to COPD